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Abstract 
 
Background and aims: Tumor necrosis factor (TNF) is a cytokine that promotes 
inflammation and contributes to pathogenesis of inflammatory bowel diseases. Unlike other 
cells and tissues, intestinal epithelial cells undergo rapid cell death upon exposure to TNF, by 
unclear mechanisms. We investigated the roles of inhibitor of apoptosis proteins (IAPs) in the 
regulation of TNF-induced cell death in the intestinal epithelium of mice and intestinal 
organoids. 
 
Methods: RNA from cell lines and tissues and analyzed by quantitative PCR, protein levels 
were analyzed by immunoblot assays. BIRC2 (also called cIAP1) was expressed upon 
induction from lentiviral vectors in young adult mouse colon (YAMC) cells. YAMC cells, the 
mouse colon carcinoma cell line MC38, the mouse macrophage cell line RAW 264.7, or 
mouse and human organoids were incubated with Smac-mimetic compound LCL161 or 
recombinant TNF-like weak inducer of apoptosis (TNFSF12) along with TNF, and cell death 
was quantified. C57BL/6 mice with disruption of Xiap, Birc2 (encodes cIAP1), Birc3 (encodes 
cIAP2), Tnfrsf1a, or Tnfrsf1b (Tnfrsf1a and b encode TNF receptors) were injected with TNF 
or saline (control); liver and intestinal tissues were collected and analyzed for apoptosis 
induction by cleaved caspase 3 immunohistochemistry. We also measured levels of TNF and 
alanine aminotransferase in serum from mice.  
 
Results: YAMC cells, and mouse and human intestinal organoids, died rapidly in response 
to TNF. YAMC and intestinal crypts expressed lower levels of XIAP, cIAP1, cIAP2, and 
cFLIP than liver tissue. Smac-mimetics reduced levels of cIAP1 and XIAP in MC38 and 
YAMC cells, and Smac-mimetics and TWEAK increased TNF-induced cell death in YAMC 
cells and organoids—most likely by sequestering and degrading cIAP1. Injection of TNF 
greatly increased levels of cell death in intestinal tissue of cIAP1-null mice, compared to wild-
type C57BL/6 mice, cIAP2-null mice, or XIAP-null mice. Excessive TNF-induced cell death in 
the intestinal epithelium was mediated TNF receptor 1. 
 
Conclusion: In a study of mouse and human cell lines, organoids, and tissues, we found 
cIAP1 to be required for regulation of TNF-induced intestinal epithelial cell death and 
survival. These findings have important implications for the pathogenesis of TNF-mediated 
enteropathies and chronic inflammatory diseases of the intestine. 
 
Key words: TWEAK, TNF signaling, IBD, mouse model 
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Introduction 
 
Tumor Necrosis Factor-α (TNF) is a cytokine with a broad spectrum of activities. Though 
predominantly expressed by activated macrophages and dendritic cells, a large variety of 
different cell types, including epithelial cells in different tissues can produce TNF 1, 2. TNF is 
one of the first cytokines released during an immune response and generally has important 
regulatory functions in the control of immunological processes due to its potent pro-
inflammatory properties 3. When TNF binds to its receptors, TNFR1 and TNFR2, it triggers a 
series of signaling cascades, generally leading to cellular activation, gene expression and 
survival 4. These cellular responses are often initiated by the activation of MAP kinases and 
NF-κB. Many of the TNF-induced and NF-κB-regulated target genes are also cytokines with 
pro-inflammatory activities, including TNF itself, leading to amplification and spreading of the 
initial inflammatory stimulus 5. TNF is not only critical during the onset of protective immune 
responses, but is also involved in the pathogenesis of numerous acute and chronic 
inflammatory diseases, including inflammatory bowel disease (IBD) 6 and rheumatoid arthritis 
(RA) 7. Thus, TNF is an important therapeutic target, and TNF-neutralizing drugs are 
successfully used in the treatment of chronic inflammatory diseases, such as RA and IBD. 
 
Although TNF has pro-inflammatory properties promoting cellular activation, proliferation and 
survival, historically it was the first cell death (necrosis)-promoting cytokine identified due to 
its ability to induce necrotic cell death in transplanted tumor tissue 8. It became the founding 
member of a large family of ligands with diverse functions and activities. Among these, 
Fas/CD95 ligand (FasL, TNFSF6) and TNF-related apoptosis-inducing ligand (TRAIL, 
TNFSF10) are particularly well known for their potent cell death-promoting activities 9. While 
FasL and TRAIL induce cell death in a large variety of cell lines and/or tissues, most cells 
and tissues are generally resistant to TNF-induced cell death. This resistance is explained by 
the fact that TNF-induced NF-κB activation promotes the expression of various survival 
proteins (e.g. cFLIP), which prevent TNF-induced apoptosis or necroptosis 10, 11.  
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Though TNF alone fails to trigger cell death in most tissues and cell types, there is one 
important exception, the intestinal epithelium. TNF injection or induction of TNF expression in 
vivo (e.g. after LPS injection and associated macrophage activation) leads to a very rapid 
induction of intestinal epithelial cell death, resulting in almost immediate shedding of mature 
epithelial cells from the villus tip and a somewhat delayed apoptosis of intestinal crypt cells 
12
. TNF-induced intestinal epithelial cell death is observed during the pathogenesis of a 
variety of inflammatory diseases, including sepsis, Graft-versus-Host disease 13, bacterial 
and viral infections 14, 15 and in particular IBD 1, 16, 17. Neutralization of TNF substantially 
reduces intestinal epithelial cell death under these inflammatory conditions and importantly 
contributes to improved survival. The reasons for this exquisite sensitivity of intestinal 
epithelial cells (IECs) to TNF is presently unknown and poorly investigated, but is likely to be 
very important for the regulation of TNF-induced intestinal immunopathologies, such as IBD. 
 
Inhibitor of apoptosis proteins (IAPs) are a group of proteins related to baculovirus IAP. 
Mammalian cells express XIAP (X-linked IAP), cIAP1 (cellular IAP1) and 2, NAIP (neuronal 
IAP) and survivin 18, 19.  Most IAPs are directly or indirectly involved in the regulation of cell 
death. While baculovirus IAP was initially described as a caspase inhibitor, characterization 
of mammalian IAPs (cIAP1, cIAP2 and XIAP) revealed that they can also regulate cell death 
via their E3 ubiquitin ligase activity (reviewed in 19). In particular cIAP1 and 2 are recruited to 
the receptor complex of various TNF receptor family members, and regulate the activity of 
other co-recruited signaling proteins by ubiquitination 20, 21. The role of IAPs has been 
particularly well characterized for TNFR1 signaling. cIAP1 and 2 are recruited to TNFR1 via a 
TRADD/TRAF2-dependent process and ubiquitinate other signaling proteins of the TNFR1 
receptor complex, including RIPK1 (receptor-interacting kinase 1) 22, 23. Absence of cIAP1 
and 2, or their pharmacological inhibition by Smac (Second mitochondrial activator of 
caspases)-mimetics generally results in sensitization of cells to TNF-induced cell death due 
to inhibition of the induction of protective NF-κB-dependent survival signals, the formation of 
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the pro-apoptotic TNFR1-induced complex II, or the RIPK1/RIPK3-dependent induction of 
necroptosis 24, 25 26. 
 
While cIAP1 and 2 have overlapping activities, their respective roles in the regulation of TNF-
induced cell death in specific cell types and tissues are incompletely understood 27. In 
particular their relative contribution to the high sensitivity of IECs to TNF-induced cell death 
and associated enteropathy has not been explored. Here we show that IECs express only 
low levels of IAPs compared to liver tissue. Smac-mimetics further sensitize mouse and 
human IEC to TNF-induced cell death in vitro, and genetic deletion of cIAP1, but not cIAP2 
or XIAP, results in massive acceleration of TNF-induced IEC cell death and enteropathy in 
vivo. TWEAK, that triggers recruitment of cIAP1 and cIAP2 to the TWEAK receptor Fn14 and 
thus depletes the cytosolic pool of these proteins 28, 29, was also found to sensitize IEC to 
TNF-induced cell death in vitro and in vivo. Our findings show that cIAP1 expression is a 
limiting and non-redundant factor in the regulation of TNF-induced cell death in the intestinal 
epithelium. Thus, cIAP1-regulated TNF sensitivity likely plays a critical role in TNF-mediated 
tissue destruction and the pathogenesis of intestinal immunopathologies, such as IBD. 
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Materials and Methods 
 
Mice 
C57BL/6, Tnfrsf1a -/- (TNFR1-null), Tnfrsf1b-/- (TNFR2-null) and Xiap-/- 30 mice were bred and 
kept in individually ventilated cages at the central animal facility of the University of 
Konstanz, Birc2-/- (cIAP1-null), Birc2-/-  x Tnfrsf1a-/- and Birc2-/- x Tnfrsf1b-/-  mice at the animal 
of the University of Zürich (Switzerland) and Birc3-/- (cIAP2-null)   mice 31 at the animal facility 
of the Walter and Eliza Hall Institute (WEHI) in Melbourne (Australia). As controls wild-type 
C57BL/6 mice from the respective animal facility were used.  
 
Cell lines 
The conditionally immortalized young adult mouse colon (YAMC) cell line (kind gift of R. 
Whitehead, Vanderbuilt University) 32 was maintained at permissive conditions (33°C, 5% 
CO2) in RPMI 1640 medium (Sigma), supplemented with 5% fetal calf serum (FCS, PAA), 
ITS solution (Gibco), 50 µg/ml Gentamicin (Sigma) and 5 U/ml mIFNγ. Six hours prior to 
treatment, YAMC cell culture was changed to 37°C, 5 % CO2 and medium without mIFNγ. 
The mouse colon carcinoma cell line MC38 was obtained from American type culture 
collection (ATCC) and cultured in IMDM (Sigma), 10% FCS, MEM amino-acid solution 
(Sigma), 4 mM L-glutamine and 50 µg/ml gentamycin (Sigma) at 37°C and 5% CO 2. The 
mouse macrophage cell line RAW 264.7 was obtained from ATCC and maintained in DMEM, 
10% FCS and 50 µg/ml gentamicin. 
 
Antibodies and reagents 
Antibodies against cleaved caspase 3 (Asp175, #9661), cIAP-1 (#4952) and Bcl-xL (#2764) 
were purchased from Cell Signaling Technology. Antibody against c-Flip (#ADI-AAP-440E) 
was purchased from Enzo Life Sciences, anti-tubulin antibody (#T5168) was purchased from 
Sigma-Aldrich, EGF (#315-09), Noggin (#250-38), IFNγ (#315-05), and R-Spondin-1 (#120-
38) were purchased from Peprotech. The Smac mimetic compound LCL161 was kindly 
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provided by Norvartis (Basel, Switzerland). Mouse recombinant TWEAK and BV6 was 
produced as described previously 29, 33, 34. 
 
RNA isolation and quantitative PCR 
Total RNA from cell lines and tissue was isolated and reverse transcribed using the High 
Capacity cDNA Reverse Transcriptions Kit (Applied Biosystems). Quantitative PCR was 
done on a StepOnePlus Real-Time PCR system (Applied Biosystems) using SYBR green 
master mix (Applied Biosystems) All gene-specific primers were designed to span an exon-
exon junction. For cFLIPS and cFLIPL splice variant-specific primer sequences were used. 
Gene expression was normalized using β-actin. Primer sequences used are listed in 
supplementary Table 1.  
 
Intestinal crypt isolation and organoid culture 
Isolation and culture of mouse and human intestinal crypts were done as described 
previously 35, 36. Mouse organoids were cultured in 96-well plates, and human organoids in 
24-well plates for 3 days (37 °C, 5% CO 2) before indicated treatments. 
 
Lentiviral transduction of YAMC cells  
YAMC cells were transduced using a 4-hydroxytamoxyfen-inducibel lentiviral contructs 
resulting in inducible expression of cIAP1 37. Cell were cultured with or without 60 nM 4-
hydroxytamoxifen for 16 h, exposed to increasing concentrations of TNF and cell death was 
assessed by MTT assay. 
 
Cell death assay for organoids and cell lines 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays in mouse 
organoids and cell lines were done as described previously 35. Cell death in human 
organoids was detected using an M30 CytoDeath ELISA (VLVbio, Nacka, Sweden) and 
normalized to the DNA content in the sample. 
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Western Blot 
Cells were lysed in NP-40 lysis buffer (150 mM NaCl, 1% NP-40, 50 mM Tris, pH 8.0 1 mM 
EDTA). Concentration of total protein was determined using BCA assay (Pierce) after 
manufacturer’s recommendation. Samples were boiled with SDS-sample buffer (95°C, 5 
min), resolved on SDS-PAGE gels (12%) and transfered a PVDF membrane. Immunoblot 
analyses were performed using specific antibodies and visualized with a biomolecular imager 
(ImageQuant LAS4000, Fujifilm). 
 
Determination of cell death by flow cytometry 
Cells and supernatant of 24-well plates were harvested, centrifuged at 1000 x g, 4°C, 5 min 
and resuspended in Annexin-V binding buffer (10 mM HEPES, 150 mM NaCl, 5 mM KCl, 1 
mM MgCl2, 1.8 mM CaCl2) with 1 µg/ml FITC-labeled Annexin V. Cell suspension was 
analyzed using a LSFortessa cytometer (BD Biosciences). 
 
Immunohistochemistry 
Mice were injected with PBS control or 4 µg mTNF or hFcTNF for 4h. Serum was harvested, 
and tissue from small intestine, large intestine and liver was collected, formalin fixed, 
dehydrated and paraffin embedded. Apoptotic cells in tissue sections were detected using an 
anti-cleaved caspase 3 antibody as described previously 38. Quantification of cleaved 
caspase 3-positive cells per 100 crypts was done in the small intestine. 
 
Transaminase assay 
For quantitative determination of alanine aminotransferase (ALT) activity in the serum of 
mice, ALT reagent colorimetric endpoint method kit (Teco Diagnostics) was used after 
manufacturer’s recommendation with 1:5 diluted serum. 
 
TNF ELISA 
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TNF in the serum was detected using a commercially available ELISA (BioLegends). 
 
Statistics 
Graph Pad Prism software (GraphPad Software, Ver 5.01) was used for statistical analysis. 
All experiments were performed in triplicates and repeated at least three times. All values are 
reported as mean ± S.D. Where indicated, statistical analysis was evaluated with unpaired 
two-tailed Student’s t-tests, with a P value of <.05 considered statistically significant. When 
multiple groups were compared, one-way ANOVA was performed. 
 
Study approval 
All animal experiments complied with animal experimentation regulations of Germany, 
Switzerland and Australia, and were approved by the Ethics Review Committee of the 
respective regional council. Experiments using human tissue samples were approved by the 
institutional ethics committee on human research of the Julius-Maximilians-University 
Würzburg (study approval number 182/10). 
 
Results 
 
TNF induces cell death in intestinal epithelial cells in vivo and in vitro 
TNF contributes to the pathogenesis of different inflammatory diseases of the intestine, at 
least in part via the direct induction of cell death in IECs and associated disruption of the 
epithelial barrier function 39. The underlying reason why IECs are so sensitive to TNF is not 
understood. In order to study the mechanisms of TNF-induced cell death in IECs, we first 
aimed at establishing an in vitro/ex vivo model system recapitulating TNF-induced IEC 
apoptosis in vivo. Mice were thus injected with a sublethal dose of soluble mouse TNF 
stimulating particularly TNFR1 40. After 6 h mice were euthanized and tissue sections were 
analyzed for apoptosis induction by staining for cleaved caspase 3, indicative of ongoing 
apoptosis in the tissue 38. While very few cleaved caspase 3-positive cells were detected in 
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the small and large intestine of control treated mice, a high frequency of apoptotic cells was 
detected after TNF injection, in both small and large intestine (Fig. 1A). Cell death detection 
was particularly prominent in the intestinal crypts. In contrast, TNF injection (in the absence 
of a tissue-specific sensitizer, such as GalN) failed to promote detectable cleaved caspase 3-
positive cells in the liver (Fig. 1A). 
 
Since apoptosis was predominantly detected in intestinal crypts, TNF-induced cell death was 
further studied in ex vivo cultured intestinal organoids 35, 41. Stimulation of these organoids 
with TNF resulted in a rapid loss of organoid integrity and the appearance of cells with 
altered morphology, which were propidium iodide positive (Fig. 1B) 35. The rapid induction of 
organoid death was further confirmed using a quantitative viability staining method (Fig. 1C).  
 
We further analyzed which TNF receptor mediates cell death in isolated mouse intestinal 
organoids. In agreement with the in vivo findings 42 we observed an almost complete 
abrogation of TNF-induced cell death in Tnfrsf1a-deficient (TNFR1-null) organoids, while 
organoids from wild-type and Tnfrsf1b-deficient (TNFR2-null) mice showed a dose-
dependent response, though organoids from TNFR2-null mice exhibited a somewhat 
reduced cell death (Fig. 1C). This indicates that both TNF receptors mediate cell death in 
IECs, but predominantly TNFR1. TNF sensitivity was also confirmed in human organoids 
(Fig. 1D) 
 
We next set out to identify an intestinal cell line, which shows similar responses to TNF as 
primary IECs. When the intestinal epithelial cell line YAMC (young adult mouse colonocytes) 
43
 was exposed to increasing concentrations of TNF, a dose-dependent induction of cell 
death was detected (Fig. G). In contrast, the macrophage cell line RAW 264.7 failed to die in 
response to TNF alone, but required sensitization via actinomycin D (Fig. 1H). 
 
Intestinal epithelial cells express low levels of IAPs 
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In order to understand the basis of the high sensitivity of IECs to TNF-induced cell death we 
investigated the relative expression of apoptosis-regulating proteins in primary IEC and 
YAMC cells in comparison to liver, RAW264.7 and the mouse colorectal tumor cell lines 
MC38, that are insensitive to TNF-induced cell death. High protein levels of XIAP and cIAP1 
were detected in liver extracts, whereas crypts expressed relatively high levels of cIAP1 but 
low levels of XIAP. YAMC cells were expressing low levels of both proteins (Fig. 2A). A 
similar finding was made for cFLIPS and cFLIPL. In comparison, relatively high expression 
levels of Bcl-xL were found in all cells and tissues. These findings on a protein level were 
confirmed by quantitative RT-PCR, where, compared to the liver, intestinal crypts and YAMC 
cells expressed much lower levels of Xiap, Birc2  (cIAP1), Birc3 (cIAP2), and cFlip (Fig. 2B). 
 
Smac-mimetics further sensitize IEC to TNF-induced cell death 
We next assessed the effect of the IAP inhibitor and Smac-mimetics on TNF-induced cell 
death. As reported previously in other cell types 44 we observed that LCL161 caused a dose-
dependent decrease in cIAP1 and XIAP levels in C38 cells, and confirmed the degradation 
of the proteins in primary mouse intestinal crypts (Fig. 3A). Treatment of YAMC cells with 
LCL161 resulted in a profound sensitization to TNF-induced cell death (Fig. 3B) but not 
chemotherapeutic drug-induced cell death (Fig. 3C and D). This sensitizing effect of IAP 
inhibition was further confirmed in primary IECs in mouse and human intestinal organoid 
cultures. Cell death induction by TNF alone was further enhanced by pretreating organoids 
with LCL161, resp. BV6, while Smac-mimetic alone resulted in only a minimal increase over 
basal cell death (Fig. 3E and F). Although Smac-mimetics have been previously shown to 
promote cell death via the activation of the NF-κB pathway, induction of TNF expression and 
TNF-mediated cell death 25, we failed to detect Smac-mimetic-induced TNF in the 
supernatant of YAMC cells (Suppl. Fig. 1).  
 
TWEAK sensitizes IEC to TNF-induced cell death 
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TWEAK (TNFSF12) is a member of the TNF family, which has been found to regulate IEC 
cell death during T helper 2 (IL-13)-mediated experimental colitis 45, 46. Furthermore, TWEAK 
has been shown to sensitize cells to FasL- and TNF-induced cell death by promoting the 
sequestration and degradation of TRAF2 and cIAP1 29, 47, 48. We thus set out to test whether 
TWEAK-induced cIAP1 degradation could also sensitize IEC to TNF-induced cell death. 
While TWEAK alone only weakly induced cell death in YAMC cells, it potently enhanced 
TNF-induced cell death (Fig. 4A). This observation was also confirmed in primary mouse 
intestinal organoids (Fig. 4C) and a similar observation was made in human organoids (Fig. 
4D). In contrast, no sensitization to cisplatin-induced cell death was observed (Fig. 4B). To 
test the relevance of this finding in vivo, wild-type mice were either injected with TWEAK or 
TNF alone, or the combination of both. While TWEAK alone failed to induce significant 
apoptosis induction in intestinal crypts, it significantly enhanced TNF-induced crypt cell 
apoptosis, as measured by the detection of caspase 3-positive cells (Fig. 4D). These findings 
were confirmed by the detection of increased cleaved lamin A-positive crypt cells upon co-
treatment with TNF and TWEAK, though only a trend towards significant differences was 
seen (Suppl. Fig. 2)  
 
XIAP is not involved in the regulation of TNF-induced IEC cell death 
Since Smac released from the mitochondria also inhibits XIAP and thereby enhances the 
mitochondrial apoptosis pathway, we tested the role of XIAP in the regulation of TNF-induced 
intestinal crypt cell apoptosis. However, TNF-induced apoptosis, as analyzed by the 
detection of cleaved caspase 3-positive cells, was comparable in both, wild-type and XIAP-
null mice (Fig. 5A, B), indicating that regulation of TNF-induced apoptosis by XIAP is not 
relevant in intestinal crypts. Since XIAP has been implicated in the regulation of death 
receptor-induced apoptosis of type II cells 30, we also analyzed TNF-induced cell death 
induction in the liver. Yet, TNF did not promote a significant increase in alanine transaminase 
(ALT) in the serum or apoptotic cells in liver tissue (suppl. Fig. 3), indicative of liver damage, 
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either in wild-type or in XIAP-null mice (Fig. 5C). In comparison, injection of LPS plus GalN 
caused strong liver damage (Fig. 5C and suppl. Fig. 3). 
 
cIAP1 is a critical regulator of TNF-induced IEC apoptosis 
To test the role of cellular IAPs in the regulation of TNF-induced IEC cell death, we analyzed 
TNF-induced cell death in the absence of cIAP1. Injection of cIAP1-null mice with TNF 
resulted in a massive increase of IEC apoptosis, as demonstrated by the high frequency of 
cleaved caspase 3-positive cells in the small and large intestine of cIAP1-null mice in 
comparison to wild-type mice (Fig. 6A and B). Histological analysis showed that 5 h post TNF 
injection massive crypt cell death was observed, and large numbers of mature IECs were 
shed into the gut lumen, leading to excessive epithelial erosion (Suppl. Fig. 4A and B). 
Whereas wild-type mice survived 24 h and longer despite the significant induction of IEC cell 
death, cIAP1-null mice had to be euthanized after 5 h post TNF injection due to moribundity. 
Although cIAP1-null mice were exquisitely sensitive to TNF, no signs of increased 
spontaneous apoptosis were evident in control treated mice (Fig. 6 A and B). Of interest, the 
mortality of cIAP1-null mice appeared to be predominantly mediated by the massive 
induction of IEC cell death and associated enteropathy, as few signs of liver damage were 
seen in either wild-type or cIAP1-null mice (Fig. 6C and suppl. Fig. 3). The increased 
sensitivity of cIAP1-null intestinal epithelial cells was also confirmed in mouse intestinal 
organoid cultures, which showed a comparable TNF sensitivity as wild-type organoids 
treated with LCL161 (Fig. 6D). In contrast, when cIAP1 was inducibly expressed in YAMC 
cells, increased resistance to TNF was observed (Suppl. Fig. 5). An increased endogenous 
production of TNF due to the activation of the non-canonical NF-κB pathway 49 could be 
excluded as a cause for increased IEC cell death, as serum TNF levels as well as intestinal 
expression levels of TNF mRNA in cIAP1-null mice were comparable to that in wild-type and 
Xiap-deficient mice (Suppl. Fig. 6). To further analyze the respective role of TNF receptors in 
this massive induction of apoptosis in cIAP1-null mice, intestinal tissue damage was 
analyzed in Birc2-/- x Tnfrsf1a-/- (cIAP1 x TNFR1-null) and Birc2-/- x Tnfrsf1b-/- (cIAP1 x 
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TNFR2-null) double-deficient mice. Whereas deletion of Tnfrsf1b had no impact on TNF-
induced tissue damage, complete protection was seen in Tnfrsf1a-deficient mice (Fig. 6E 
and F), supporting again the idea that TNFR1 is the critical cell death-promoting TNF 
receptor. 
 
cIAP2 is not involved in the regulation of TNF-induced IEC apoptosis 
cIAP1 and 2 have often, but not always, overlapping activities 31, 49. However, when cIAP2-
null mice were injected with TNF, cell death induction in the intestinal crypts was found to be 
comparable to that observed in wild-type animals (Fig. 7A and B), indicating that cIAP2 has 
no crucial role in regulating TNF-induced cell death in IECs. In comparison, approximately a 
10-fold higher frequency in TNF-induced crypt cell death was observed in cIAP1-null mice 
treated at the same time or in a separate experiment (Fig. 7B and 6B). This finding was 
confirmed in mouse intestinal organoid cultures (Fig. 7C).  
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Discussion 
 
TNF is an important pro-inflammatory and disease-promoting cytokine involved in the 
pathogenesis of numerous inflammatory disorders. Its role in the pathogenesis of IBD is 
particularly well studied, and it is an important therapeutic target in Crohn’s disease and 
ulcerative colitis 50, 51. It can either be directly inhibited by neutralizing antibodies or soluble 
receptors or targeted indirectly by glucocorticoids, which prevent NF-κB activation, TNF 
expression and associated TNFR-induced inflammatory processes. TNF mediates its 
deleterious effects via different mechanisms. On one hand TNF promotes the expression of 
pro-inflammatory cytokines, chemokines and adhesion molecules, mostly via NF-κB-
dependent processes, and thereby induces the recruitment of immune cells to target tissues. 
Associated immune cell activation and effector functions in turn often result in excessive 
tissue damage. However, TNF may also have direct destructive and cytotoxic activities on 
cells. TNF-induced signaling in IECs leads to activation of the myosin light chain kinase, and 
associated disruption of tight junctions 52. The increase in intestinal epithelial barrier 
permeability often results in penetration of bacteria and bacterial products, stimulation of the 
immune system and triggering of a vicious cycle of inflammation and tissue destruction. 
Thus, understanding of signaling processes leading to TNF-mediated IEC cell death are very 
important in order to develop specific therapies. 
 
Here, we have specifically investigated the mechanism of epithelial damage upon exogenous 
administration of TNF. In contrast to the liver, the intestinal epithelium is exquisitely sensitive 
to the pro-apoptotic action of TNF. Confirming previous reports 42, 53, we found that TNFR1 
rather than TNFR2 is responsible for transducing the pro-apoptotic signals in IEC. We further 
provide evidence that cIAP1 contributes to the regulation of TNF sensitivity of the intestinal 
epithelium. While the intestinal epithelium in wild-type mice shows a pronounced sensitivity 
to TNF-induced cell death, this is drastically enhanced in the absence of cIAP1. Confirming 
the critical role of IAPs in regulating TNF sensitivity we found that treatment of IECs with 
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Smac-mimetics also resulted in increased sensitivity to TNF. Similarly, TWEAK, causing 
cIAP1 sequestration and degradation 29, 47, strongly enhanced TNF-induced cell death in 
vitro, ex vivo and in vivo. 
 
A remarkable observation of this study is that absence of either cIAP1, cIAP2 or XIAP alone 
does not result in excessive spontaneous cell death induction, epithelium destruction or 
inflammation, in particular because in humans mutation of XIAP has been strongly linked to 
IBD 27. Though our results show a critical role for cIAP1 in controlling TNF sensitivity, 
absence of either IAPs on its own does not cause chronic stimulation of the NF-κB pathway, 
associated TNF production, induction of apoptosis or necroptosis, and/or lethality as seen in 
RIPK1, caspase 8- or FADD-deficient mice 54-56. However, combined loss of cIAP1 and 
cIAP2, or cIAP1 and XIAP results in embryonic lethality 31. Similarly, intestinal epithelium-
specific deletion of RIPK1 does not cause the neonatal lethality observed in the complete 
RIPK1 knockout, but nevertheless results in massive intestinal inflammation and IEC 
apoptosis, and death within few weeks of life. This massive IEC apoptosis appears to be due 
to hyper-responsiveness of the intestinal epithelium to TNF/TNFR1 signaling because 
combined deletion of TNFR1 prevented the intestinal pathology in both Ripk1-/- and Ripk1IEC-
KO
 mice 57, 58. In this regard it is interesting that RIPK1 is ubiquitinated by cIAP1 and 2 in the 
TNFR complex, which contributes to resistance to TNF-induced cell death 19. Alternatively, 
RIPK1 deficiency could also lead to reduced cIAP1 expression levels, as observed by 
Dannappel 58 and Takahashi 59. This could at least explain in part the similarly increased 
sensitivity of cIAP1- and RIPK1-deficient IECs to TNF-induced cell death. It does, however, 
not explain why systemic absence of RIPK1 results in neonatal lethality and IEC-specific 
deletion of Ripk1 in massive spontaneous intestinal inflammation, whereas cIAP1 deficiency 
does not cause death or spontaneous TNF-dependent colitis. RIPK1 induces stabilization of 
TRAF2 and cIAP1, which prevent NIK stabilization and activation of the non-canonical NFκB 
pathway, potentially leading to TNF production and TNF-induced cell death 60. Upon loss of 
Ripk1 IECs produce excessive TNF, which promotes inflammation and apoptosis. Of 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Grabinger et. al. TNF-induced intestinal epithelial cell death  19
interest, neither an increase in constitutive TNF expression levels nor spontaneous intestinal 
inflammation was seen in cIAP1-null mice. Thus, deletion of cIAP1 or any IAP is likely not 
sufficient to allow spontaneous NIK activation and TNF production and associated IEC cell 
death. 
 
While we identified cIAP1 as a critical regulator of TNF-induced IEC cell death, it is surprising 
to note that Xiap, but not Birc2 (cIAP1), gene mutations have been associated with Crohn's 
disease 61. Though TNF and associated signaling pathways have been shown to be critically 
involved in the pathogenesis of IBD, and neutralization of TNF has a significant beneficial 
effect in Crohn's and colitis patients 51, we did not observe an increased susceptibility of 
Xiap-deficient mice to TNF-induced IEC apoptosis. More likely XIAP is involved in innate 
immune signaling. In this respect, it is interesting that monocytes from patients with Xiap 
mutations within the RING domain respond in a reduced manner to muramyldipeptide 
(MDP), in agreement with a recently described role of XIAP in NOD2 signaling 62. Thus, the 
role of XIAP in the regulation of IBD may be more related to NOD2 signaling, rather than 
control of TNF signaling and associated IEC death. This is highlighted by the fact that 
mutations in Nod2 are among the most frequent disease-associated mutations in IBD 
patients 63. Though all three IAPs (XIAP, cIAP1 and 2) are involved in NOD signaling 62, 64, 65, 
only cIAP1 appears to be critical for TNFR1-induced IEC cell death, resp. survival.  
 
In summary, here we show that cIAP1 is critically involved in the regulation of TNF-induced 
IEC cell death. Thus, processes, which regulate expression and stability of cIAP1 may also 
regulate the pathogenesis of TNF-mediated enteropathies. Our finding is amongst the first 
demonstration of a unique and limiting role of cIAP1 in a given signaling pathway, which is 
not redundant with cIAP2. Of interest is our observation that TWEAK sensitizes IEC to TNF-
induced apoptosis, likely in a cIAP1-dependent manner, whereas inhibition of TWEAK 
signaling in vivo improves experimental colitis 66, providing further evidence for the proposed 
mechanism. Since Smac-mimetics likely also sensitize IEC by limiting cIAP1-mediated 
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protection, the potential use of Smac-mimetics in the clinics, e.g. for sensitizing cancer cells 
to apoptosis, may also have potential side-effects on the integrity of the intestinal epithelium, 
particularly in context of simultaneous bacterial infections with high TNF production. 
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Figures and figure legends 
 
Fig. 1: TNF-induced cell death in intestinal epithelial cells in vivo and in vitro. 
 (A) Wild-type mice were injected with PBS or TNF for 4h, and apoptosis in small and large 
intestine and liver was detected using cleaved caspase 3 immunohistochemistry (n = 12 
mice per group) Scale bar = 150 µm. (B) Representative microscopic (phase contrast and 
Hoechst/propidium iodide staining) images of PBS- and TNF-treated mouse intestinal 
organoids. Scale bar = 150 µm. (C) Organoids from wild-type (WT), Tnfrsf1a-/- (TNFR1-null) 
and Tnfrsf1b-/- (TNFR2-null) mice were treated with TNF and cell death was measured by 
MTT reduction (mean ± SD of triplicates, n = 3). (D) Human organoids were treated with 
increasing doses of TNF and cell death was analyzed by M30 ELISA (mean ± SD of 
triplicates, n = 3). (E) YAMC cells were treated with indicated doses of TNF and cell death 
was assessed by MTT. Mean +/- SD of triplicate of representative experiments are shown (n 
= 4). (F) RAW 264.7 macrophage cells were either pretreated with ActD (60 ng/ml) or PBS, 
and TNF-induced cell death was measured by MTT reduction (mean ± SD of triplicates, n = 
2).  
 
Fig. 2: IAP expression in intestinal epithelial cells. 
Protein (A) and mRNA (B) expression of the indicated genes in liver, isolated crypts and the 
cell lines YAMC, MC38 and RAW 264.7. Representative immunoblots of 3 independent 
experiments are shown. Mean values ± SD of samples from three individual mice are shown 
for qPCR (n = 2). Birc2, cIAP1; Birc3, cIAP2; Cflar (short), cFLIPS; Cflar (long), cFLIPL; Vil-1, 
Villin. 
 
Fig. 3: The Smac-mimetic LCL161 sensitizes IECs to TNF-induced cell death. 
(A) MC38 and isolated crypts were treated with the indicated concentrations of LCL161 for 
2h, and protein levels of cIAP1 and XIAP were detected by immunoblotting (n = 3) (B) YAMC 
cells were pretreated with indicated concentrations of LCL161 for 2 h, and then stimulated 
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with buffer control or TNF (30 ng/ml). (C-D) YAMC cells were pretreated with indicated 
concentrations of LCL161, and stimulated with the chemotherapeutic agents cisplatin (C) or 
irinotecan (D) (Mean values ± SD of triplicates, n = 2). (E) Mouse organoids were pre-treated 
with LCL161 (30 nM), followed by stimulation with TNF (30 ng/ml). Organoid cell death was 
measured by MTT reduction. *** P <.001. Mean values ± SD of triplicates, n = 3. (F) Human 
organoids were pre-treated with BV6, then stimulated with TNF (1 ng/ml), and cell death was 
analyzed by M30 ELISA. Mean values ± SD of triplicates, n = 3 
 
Fig. 4: TWEAK sensitizes IECs to TNF-induced cell death 
YAMC cells were pretreated with indicated concentrations of TWEAK, and then treated with 
either TNF (A) or the chemotherapeutic agent cisplatin (B). Cell death was measured by 
MTT reduction. Mean values ± SD of triplicates are shown (n = 3). (C), (D) Mouse Organoids 
(C) and human organoids (D) were pretreated with TWEAK, and stimulated with PBS or 
TNF. Mean values ± SD of triplicates are shown (n=2) (E) Mice were injected with PBS or 
TWEAK (200 µg), and PBS or 10 µg TNF (n = 3 mice per group). The number of cleaved 
caspase 3-positive cells per 100 crypts was quantified. **, P < .01, * P < .05. 
 
Fig. 5: XIAP is not involved in the regulation of TNF-induced IEC cell death 
(A) Wild-type (WT) and Xiap-/- mice were injected with PBS or TNF (4 µg) and cleaved 
caspase 3-positive cells in the small intestine was analyzed (n = 4 per group; scale bar = 150 
µm). Inserts show magnification. (B) Quantification of cleaved caspase 3-positive cells in 
intestinal crypts. ** P < .01, n.s. = not significant. (C) Serum transaminase (ALT) activity of 
TNF treated WT and Xiap-/- mice  (n = 3 per group). Serum from LPS plus GalN-treated mice 
served as positive control. Individual data points and mean values are shown. 
 
Fig. 6: cIAP1 is a critical regulator of TNF-induced IEC apoptosis 
(A) Wild-type (WT) or cIAP1-null (Birc2-/-) mice were treated with PBS or TNF (4 µg), and 
apoptosis in small and large intestine was detected using cleaved caspase 3 
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immunohistochemistry (n = 6 per group; scale bar = 150 µm). Insets show magnifications. 
(B) Apoptotic cells within the crypt region of tissue from the same experiment were 
quantified. * P < .05, ** P < .01. Mean values and individual data points are shown. (C) 
Serum transaminase activity of TNF-treated WT and cIap1-/- mice (n = 3 per group). ALT 
values of LPS plus GalN-treated WT mice served as positive control for excessive liver 
damage. Mean values and individual data points are shown. (D) Organoids from WT or 
cIAP1-null (Birc2-/-) mice were treated with indicated concentrations of TNF. WT organoids 
were also pretreated with LCL161 (60 nM). Cell death was measured by MTT reduction. 
Mean values of triplicates ± SD of a representative experiment are shown (n = 2). (E) WT, 
Birc2-/- (cIAP1-null), Birc2-/- Tnfrsf1a-/- (cIAP1-null TNFR1-null), and Birc2-/- Tnfrsf1b-/- (cIAP1-
null TNFR2-null) mice were injected with 4 µg TNF and cell death in small intestine was 
detected using cleaved caspase 3 immunohistochemistry. (F) Quantification of experiment 
shown in (E) (n = 3 per TNF-treated group. * p<.05, ** p<.01. 
 
Fig. 7: cIAP2 is not critical for TNF-mediated IEC cell death 
(A) Cleaved caspase 3 immunohistochemistry of small and large intestinal tissue sections 
from TNF (4 µg) or PBS-injected wild-type (WT) and Birc3-/- (cIAP2-null) mice (n = 4 per 
group; scale bar = 150 µm). (B) Quantification of apoptotic crypt cells in small intestinal 
tissue sections of TNF treated WT, Xiap-/-, Birc3-/- and Birc2-/- mice (n = 3-5 mice per group). 
Individual data points and mean values are shown. ** P < .01, n.s. = not significant. (C) 
Intestinal organoids of WT, Birc2-/- and Birc3-/- mice were treated with indicated 
concentrations of TNF. Cell death was determined by MTT reduction. Mean values of 
triplicates ± SD of a representative experiment (n = 2) are shown.  
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